&Partners’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History
Bought
Maintained
Sold
Other funds holding ECAT
SCM
PCM
AAM
&Partners's ECAT Position: Q1 2026 in Review
&Partners increased its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 4.1% in Q1 2026, buying an estimated $15K and bringing the position to 25,462 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1898.
&Partners first reported a position in ECAT in Q2 2024 and has held it in 3 quarters since. The position peaked at $376K in Q4 2025. 84 funds tracked by Wall St. Rank hold ECAT as of Q1 2026.
- &Partners held 25,462 shares of BlackRock ESG Capital Allocation Term Trust worth $346K as of Q1 2026.
- &Partners bought 1,001 BlackRock ESG Capital Allocation Term Trust shares in Q1 2026, an estimated $15K.
- BlackRock ESG Capital Allocation Term Trust made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1898 holding.
- &Partners first reported a position in BlackRock ESG Capital Allocation Term Trust in Q2 2024 and has held it in 3 quarters since.
- &Partners's BlackRock ESG Capital Allocation Term Trust position peaked at $376K in Q4 2025.
- 84 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2026.
Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.